UY25750A1 - Pirazolo [4,3-d] pirimidin-7-onas y sus intermedios - Google Patents

Pirazolo [4,3-d] pirimidin-7-onas y sus intermedios

Info

Publication number
UY25750A1
UY25750A1 UY25750A UY25750A UY25750A1 UY 25750 A1 UY25750 A1 UY 25750A1 UY 25750 A UY25750 A UY 25750A UY 25750 A UY25750 A UY 25750A UY 25750 A1 UY25750 A1 UY 25750A1
Authority
UY
Uruguay
Prior art keywords
pirazolo
pirimidin
onas
intermediates
compounds
Prior art date
Application number
UY25750A
Other languages
English (en)
Inventor
Peter James Dun Philip Levett
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY25750(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of UY25750A1 publication Critical patent/UY25750A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de fórmulas (IA) (sildenafil/Viagra TM) y (IB), y compuestos claves intermedios para su preparación.
UY25750A 1998-10-12 1999-10-12 Pirazolo [4,3-d] pirimidin-7-onas y sus intermedios UY25750A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
UY25750A1 true UY25750A1 (es) 2001-08-27

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25750A UY25750A1 (es) 1998-10-12 1999-10-12 Pirazolo [4,3-d] pirimidin-7-onas y sus intermedios

Country Status (49)

Country Link
US (3) US6207829B1 (es)
EP (1) EP0994115B1 (es)
JP (1) JP3721021B2 (es)
KR (1) KR100380954B1 (es)
CN (2) CN1207295C (es)
AP (1) AP1233A (es)
AR (1) AR019244A1 (es)
AT (1) ATE290003T1 (es)
AU (1) AU756463B2 (es)
BG (1) BG63205B1 (es)
BR (1) BR9905092A (es)
CA (1) CA2285733C (es)
CO (1) CO5150214A1 (es)
CR (1) CR6118A (es)
CU (1) CU22928A3 (es)
CZ (1) CZ296816B6 (es)
DE (1) DE69923906T2 (es)
DK (1) DK0994115T3 (es)
DZ (1) DZ2912A1 (es)
EA (1) EA003774B1 (es)
EE (1) EE04192B1 (es)
EG (1) EG22630A (es)
ES (1) ES2237049T3 (es)
GB (1) GB9822238D0 (es)
GE (1) GEP20022700B (es)
GT (1) GT199900172A (es)
HK (1) HK1027559A1 (es)
HR (1) HRP990318B1 (es)
HU (1) HU226162B1 (es)
ID (1) ID23351A (es)
IL (11) IL132273A (es)
IS (1) IS1951B (es)
MA (1) MA25007A1 (es)
MY (1) MY124620A (es)
NO (1) NO313700B1 (es)
OA (1) OA11165A (es)
PE (1) PE20001086A1 (es)
PL (1) PL198150B1 (es)
PT (1) PT994115E (es)
RS (1) RS49762B (es)
SG (1) SG118060A1 (es)
SI (1) SI0994115T1 (es)
SK (1) SK285215B6 (es)
TN (1) TNSN99189A1 (es)
TR (1) TR199902541A2 (es)
TW (1) TW589314B (es)
UA (1) UA66787C2 (es)
UY (1) UY25750A1 (es)
ZA (1) ZA996412B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
AU6259701A (en) * 2000-06-22 2002-01-02 Dunn Peter James Process for the preparation of pyrazolopyrimidinones
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
ATE455758T1 (de) 2001-12-20 2010-02-15 Merck Serono Sa Pyrrolidin-derivatie als prostaglandin- modulatoren
WO2003059258A2 (en) * 2001-12-21 2003-07-24 Cytokinetics, Inc. Compositions and methods for treating heart failure
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
ES2378620T3 (es) * 2003-03-27 2012-04-16 Cytokinetics, Inc. Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze

Also Published As

Publication number Publication date
PL198150B1 (pl) 2008-05-30
NO994943L (no) 2000-04-13
GT199900172A (es) 2001-03-28
US6207829B1 (en) 2001-03-27
SK138599A3 (en) 2000-05-16
IL152928A0 (en) 2003-06-24
CN1255497A (zh) 2000-06-07
OA11165A (en) 2003-04-22
ZA996412B (en) 2001-04-11
HRP990318B1 (en) 2004-06-30
HUP9903469A2 (hu) 2000-08-28
SG118060A1 (en) 2006-01-27
ID23351A (id) 2000-04-13
IL152926A0 (en) 2003-06-24
IL152923A (en) 2004-02-08
DZ2912A1 (fr) 2004-03-01
HU9903469D0 (en) 1999-12-28
IL152927A (en) 2004-06-01
EP0994115A3 (en) 2000-05-24
US20010009962A1 (en) 2001-07-26
IL132273A0 (en) 2001-03-19
DE69923906D1 (de) 2005-04-07
TNSN99189A1 (fr) 2005-11-10
EA003774B1 (ru) 2003-08-28
AU756463B2 (en) 2003-01-16
IS5209A (is) 2000-04-13
EP0994115B1 (en) 2005-03-02
EA199900822A2 (ru) 2000-04-24
EA199900822A3 (ru) 2000-08-28
IL152924A (en) 2004-02-19
YU48999A (sh) 2002-06-19
IL152926A (en) 2004-02-19
PT994115E (pt) 2005-06-30
HRP990318A2 (en) 2000-06-30
CN1207295C (zh) 2005-06-22
PL335959A1 (en) 2000-04-25
ATE290003T1 (de) 2005-03-15
KR100380954B1 (ko) 2003-04-21
IL152927A0 (en) 2003-06-24
TW589314B (en) 2004-06-01
AP1233A (en) 2003-12-18
EE9900507A (et) 2000-06-15
EP0994115A2 (en) 2000-04-19
BR9905092A (pt) 2000-08-08
KR20000028987A (ko) 2000-05-25
NO313700B1 (no) 2002-11-18
TR199902541A2 (xx) 2000-07-21
DK0994115T3 (da) 2005-06-20
JP2000119273A (ja) 2000-04-25
CR6118A (es) 2005-09-16
EE04192B1 (et) 2003-12-15
AR019244A1 (es) 2001-12-26
AP9901672A0 (en) 1999-12-31
CN1473831A (zh) 2004-02-11
RS49762B (sr) 2008-04-04
CO5150214A1 (es) 2002-04-29
CZ296816B6 (cs) 2006-06-14
GEP20022700B (en) 2002-05-27
IS1951B (is) 2004-10-13
IL152928A (en) 2007-07-04
AU5358199A (en) 2000-04-13
HU226162B1 (en) 2008-05-28
GB9822238D0 (en) 1998-12-09
MY124620A (en) 2006-06-30
CA2285733C (en) 2004-08-24
ES2237049T3 (es) 2005-07-16
MA25007A1 (fr) 2000-07-01
IL152924A0 (en) 2003-06-24
DE69923906T2 (de) 2006-04-06
CZ353299A3 (cs) 2000-05-17
BG63205B1 (bg) 2001-06-29
UA66787C2 (en) 2004-06-15
CU22928A3 (es) 2004-02-20
IL152923A0 (en) 2003-06-24
JP3721021B2 (ja) 2005-11-30
NO994943D0 (no) 1999-10-11
US20030069422A1 (en) 2003-04-10
SK285215B6 (sk) 2006-09-07
IL132273A (en) 2004-06-20
BG103794A (en) 2000-09-29
SI0994115T1 (es) 2005-08-31
CA2285733A1 (en) 2000-04-12
PE20001086A1 (es) 2000-10-18
HUP9903469A3 (en) 2000-10-30
HK1027559A1 (en) 2001-01-19
EG22630A (en) 2003-05-31

Similar Documents

Publication Publication Date Title
UY25750A1 (es) Pirazolo [4,3-d] pirimidin-7-onas y sus intermedios
ES2159346T3 (es) Formas cristalinas de un derivado de tieno(2,3-b)(1,5)benzodiazepina y procedimiento para su preparacion.
AU6392899A (en) Dynamic matching TM of users for group communication
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
AU2001263481A1 (en) Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks
AU6583898A (en) Integration of hollow waveguides, channels and horns by lithographic and et chingtechniques
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
NO20010684D0 (no) Substituert 1,8-Naphthyridin-4(1H)-on som fosfodiesterase 4 inhibitorer
ES2139216T3 (es) Procedimiento para la preparacion de espumas flexibles.
DE69708591D1 (de) Schlüsselzwischenprodukte zur Herstellung von Simvastatin
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
MX217365B (es) Formulacion de suspencion concentrada que contiene pirimetanilo.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
ES2151991T3 (es) Procedimiento para preparar un derivado de tieno(2,3-b)(1,5)benzodiacepina.
BR0212153A (pt) Compostos e respectivos processos de preparação e de isolamento de dicloreto de 2-difluormetilornitina
BR0112600A (pt) Compostos calcilìticos
HN1999000101A (es) Inhibidores de las fkbp.
HK1049336A1 (en) Synthetic routes for the preparation of rhinovirusprotease inhibitors and key intermediates.
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
IS5654A (is) Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim
AU2001277728A1 (en) Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof
AU2002216033A1 (en) Use of pyrazolo(4,3-d)pyrimidines
GT199900223A (es) Pirazolo(4,3-d)pirimidin-7-onas y sus intermediarios.
ES1039334Y (es) Buzon-cesta de uso comunitario para la recepcion de publicidad.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140210